Form 4: CalciMedica President and COO Acquires Stock Options

Michael J. Dunn, President and COO of CalciMedica, Inc., reports the acquisition of employee stock options.

Summary

• Michael J. Dunn, the President and COO of CalciMedica, Inc. [CALC], filed a Form 4 on August 28, 2024, reporting a transaction.
• On August 27, 2024, Dunn acquired 62,500 employee stock options with an exercise price of $4.16.
• These options vest in equal monthly installments over a four-year period following March 28, 2024, with 1/48th of the shares vesting each month.
• The options expire on August 26, 2034.
• Following the reported transaction, Dunn directly owns 62,500 derivative securities.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The acquisition of stock options by an executive is generally viewed as a slightly positive sign, but it's a routine occurrence.

Positives

• The acquisition of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• Shareholders may view the acquisition of stock options by a company executive as a positive sign, indicating confidence in the company's future performance.

Key Dates